Results 61 to 70 of about 48,299 (277)
Inflammation and Restenosis in the Stent Era [PDF]
Arteriosclerosis, Thrombosis, and Vascular Biology, 2002 The pathophysiology of restenosis involves early elements of direct injury to smooth muscle cells, deendothelialization, and thrombus deposition. Over time, this leads to smooth muscle cell proliferation/migration and extracellular matrix deposition. There is an increasing body of evidence to suggest that inflammation plays a pivotal role linking early
Campbell Rogers, Frederick G.P. Welt
openaire +2 more sources
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Pseudoaneurysm (PA) is a well‐known vascular complication following percutaneous interventions, typically occurring in the early post‐procedural period. However, delayed‐onset PA associated with deep vein thrombosis (DVT) is an uncommon presentation.
Sefa Tatar +3 more
wiley +1 more source
Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2018 Aim.To analyze the literature data about the role of adiponectin, P-selectin and integrin β3 in the pathogenesis of the development of in-stent restenosis in patients with coronary heart disease after coronary stenting, as well as the possibility of ...
Chernyak A. A., Snezhitskiy V. A.
doaj +1 more source
The Hybrid Approach to Intervention of Chronic Total Occlusions [PDF]
, 2015 The "hybrid" approach to chronic total occlusion (CTO) percutaneous coronary intervention (PCI) was developed to provide guidance on optimal crossing strategy selection.
Banerjee, S +6 more
core +1 more source
Stent Strut Thickness and Restenosis [PDF]
Circulation, 2002 To the Editor: Kastrati et al recently reported1 significantly less restenosis with lesions randomized to deployment of one stent design (ACS RX Multi-Link, [ML]) than with a related design (Multi-Link RX Duet, [DT]) from the same manufacturer (Guidant). They attributed the difference in restenosis to the difference in strut thickness.
Peter Ruygrok +2 more
openaire +3 more sources
Drug Coated Balloons Versus Drug‐Eluting Stents in Patients With De Novo Coronary Artery Disease
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background In patients with de novo coronary artery disease (CAD), percutaneous coronary intervention (PCI) with drug eluting stent (DES) implantation is the gold standard therapy. New evidence is available with drug coated balloons (DCB) angioplasty. The objective of this meta‐analysis was to compare the efficacy and safety of DCB angioplasty
Daniel O'Callaghan +9 more
wiley +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Initially, drug‐coated balloon (DCB) angioplasty was primarily employed for in‐stent restenosis (ISR) treatment. Over time, its indications have broadened to include de novo small‐vessel lesions and bifurcation lesions. However, there is a lack of effective strategies to reduce restenosis rates post‐DCB angioplasty.
Chenhang Wang, Li Chen, Xiaoyong Xu
wiley +1 more source
Perfil dos pacientes submetidos à angioplastia trasluminal coronariana com stents farmacológicos no Instituto de Cardiologia de Santa Catarina. [PDF]
, 2007 Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Aquino, Vivian Wuerges de
core
Multifunctional star-shaped polylactic acid implants for use in angioplasty [PDF]
, 2014 Star-shaped polylactic acids with different tacticity were synthesized and both polymers are capable of bestowing properties of anticoagulation and angiogenesis to their living host.
Kiran, M. S. +3 more
core +2 more sources
Results of Coronary Stenting for Restenosis
Journal of the American College of Cardiology, 1996 This study attempted to analyze immediate and long-term angiographic and clinical results of coronary stent implantation for restenosis in a consecutive group of patients.The rate of stent utilization in patients with coronary artery disease has increased exponentially in recent years.
Akira Itoh +5 more
openaire +3 more sources